ROHTO PHARMACEUTICAL CO.,LTD.
4527ロート製薬株式会社
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-14For the first half of the fiscal year to 2026-03: Revenue ¥164.3 billion (+18.1% YoY), Ordinary income ¥24.6 billion (+32.4% YoY), Net income ¥17.7 billion (+36.6% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥164.3bn | +18.1% |
| Ordinary profit | ¥24.6bn | +32.4% |
| Net profit to owners | ¥17.7bn | +36.6% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4527/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2026-03-31- Revenue
- ¥343.7bn
- Net income
- ¥34.2bn
- ROE
- 12.1%
- Equity ratio
- 62.1%
- Dividend / share
- ¥46
- Employees
- 9,292
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥343.7bn | ¥34.2bn | ¥485.8bn | ¥320.2bn | 12.1% | ¥151.56 | ¥47.8bn |
| 2025-03-31 | ¥308.6bn | ¥30.8bn | ¥437.0bn | ¥280.7bn | 12.1% | ¥135.38 | ¥36.9bn |
| 2024-03-31 | ¥270.8bn | ¥30.9bn | ¥346.2bn | ¥247.0bn | 13.6% | ¥135.61 | ¥34.2bn |
| 2023-03-31 | ¥238.7bn | ¥26.4bn | ¥309.7bn | ¥215.1bn | 13.6% | ¥115.62 | ¥30.9bn |
| 2022-03-31 | ¥199.6bn | ¥21.1bn | ¥274.9bn | ¥184.0bn | 12.7% | ¥92.61 | ¥27.3bn |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 12.1 | 68.1 |
| Ordinary margin | 0.1396 | 80.5 |
| Equity ratio, % | 62.1 | 61.8 |
| Revenue growth | 0.1137 | 72.9 |
| Net income growth | 0.1104 | 47.2 |
| Operating cash flow / assets | 0.0984 | 72 |
Results wording balance: +0.79. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥52.9bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥265m, 0.6% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4527/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states them/v1/companies/4527/buybacksSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4527/segments/v1/companies/4527/votingOwnership changes
All companies →- 2024-07-29
Mitsubishi UFJ Financial Group, Inc. reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 6.53% from 7.23%.
- 2023-11-22
Massachusetts Financial Services Company reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 7.31% from 8.39%.
- 2023-05-19
Massachusetts Financial Services Company reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 8.39% from 9.43%.
- 2023-02-17
SPARX Asset Management Co., Ltd. cut holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 4.96% from 6.02%, below the 5% threshold.
- 2023-02-13
Massachusetts Financial Services Company reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 9.43% from 10.48%.
- 2023-02-13
Holdings of Massachusetts Financial Services Company in ROHTO PHARMACEUTICAL CO.,LTD. (4527) moved below 10% (10.48% -> 9.43%).
- 2022-11-08
Mitsubishi UFJ Financial Group, Inc. reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 7.23% from 8.30%.
- 2022-01-18
SPARX Asset Management Co., Ltd. reduced holdings in ROHTO PHARMACEUTICAL CO.,LTD. (4527) to 6.02% from 7.03%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| Massachusetts Financial Services Company | 2022-12-12 – 2023-02-06 | -1,017,300 | −0.40pt | ¥2,373.5 | ¥2,171–4,737 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4527/trades.
5% filings
Large shareholding reports on 4527| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2024-07-29 | Mitsubishi UFJ Financial Group, Inc. | 6.53% | −0.70pt | strategic holding |
| 2023-11-22 | Massachusetts Financial Services Company | 7.31% | −1.08pt | pure investment |
| 2023-05-19 | Massachusetts Financial Services Company | 8.39% | −1.04pt | pure investment |
| 2023-02-17 | SPARX Asset Management Co., Ltd. | 4.96% | −1.06pt | pure investment |
| 2023-02-13 | Massachusetts Financial Services Company | 9.43% | −1.05pt | pure investment |
| 2022-11-08 | Mitsubishi UFJ Financial Group, Inc. | 7.23% | −1.07pt | strategic holding |
| 2022-01-18 | SPARX Asset Management Co., Ltd. | 6.02% | −1.01pt | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 25 issues
- Book value
- ¥15.5bn
- Sold in the year
- — — issues
- Bought in the year
- ¥30m 2 issues
- Mutual, both reports
- 14
- Held by listed cos.
- 24
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Mitsubishi UFJ Financial Group, Inc. 8306 | ¥3,588m | 0.0% | both reports |
| OHKI HEALTHCARE HOLDINGS CO.,LTD. 3417 | ¥2,341m | 0.0% | both reports |
| MatsukiyoCocokara & Co 3088 | ¥1,681m | 0.0% | both reports |
| WAKAMOTO PHARMACEUTICAL CO.,LTD. 4512 | ¥1,394m | 0.0% | both reports |
| Sumitomo Mitsui Financial Group, Inc. 8316 | ¥1,067m | 0.0% | no |
| MORISHITA JINTAN CO.,LTD. 4524 | ¥789m | 0.0% | both reports |
| Meiji Holdings Co., Ltd. 2269 | ¥696m | 0.0% | both reports |
| Senshu Ikeda Holdings,Inc. 8714 | ¥696m | 0.0% | both reports |
| The Nanto Bank,Ltd. 8367 | ¥529m | +400.0% | stated |
| 養命酒製造(株) 2540 | ¥511m | 0.0% | both reports |
Held by: Mitsubishi UFJ Financial Group, Inc. 8306, The Hyakugo Bank, Ltd. 8368, Senshu Ikeda Holdings,Inc. 8714, DENTSU GROUP INC. 4324, 2540 2540, MORISHITA JINTAN CO.,LTD. 4524, Resona Holdings, Inc. 8308, 8283 8283, MEDIPAL HOLDINGS CORPORATION 7459, Meiji Holdings Co., Ltd. 2269, MatsukiyoCocokara & Co 3088, HAKUHODO DY HOLDINGS INCORPORATED 2433 and 13 more
Purposes, all holdings and mutual flags via /v1/companies/4527/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| 日本マスタートラスト信託銀行㈱(信託口) | 30,437,000 | 13.46% |
| STATE STREET BANK AND TRUST COMPANY 505223 | 12,302,000 | 5.44% |
| ㈱日本カストディ銀行(信託口) | 11,139,000 | 4.92% |
| ㈲山田興産 | 8,415,000 | 3.72% |
| ㈱三菱UFJ銀行 | 7,601,000 | 3.36% |
| 山昌興産㈱ | 5,046,000 | 2.23% |
| 日本生命保険(相) | 4,238,000 | 1.87% |
| STATE STREET BANK AND TRUST COMPANY 505001 | 3,640,000 | 1.61% |
| individual holder | 3,623,000 | 1.60% |
| ロートグループ従業員持株会 | 3,062,000 | 1.35% |
U.S. funds holding 4527
SEC Form N-PORT, reports to 2026-07-3185 U.S. funds held 27,932,601 shares worth $416.5m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| MFS International Intrinsic Value Fund MFS SERIES TRUST X | 10,218,000 | $152.8m | 0.612% | 2026-05-31 |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 3,003,044 | $45.0m | 0.007% | 2026-07-31 |
| VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS | 1,995,514 | $29.3m | 0.009% | 2026-06-30 |
| iShares Core MSCI EAFE ETF iShares Trust | 1,389,000 | $20.8m | 0.011% | 2026-07-31 |
| Mercer Non-US Core Equity Fund Mercer Funds | 715,900 | $10.5m | 0.220% | 2026-06-30 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/4527
GET /v1/companies/4527/financials
GET /v1/companies/4527/details
GET /v1/companies/4527/segments
GET /v1/companies/4527/voting
GET /v1/companies/4527/tender-offers
GET /v1/companies/4527/indicators
GET /v1/companies/4527/earnings-releases
GET /v1/events?ticker=4527
GET /v1/companies/4527/trades
GET /v1/companies/4527/cross-holdings
GET /v1/companies/4527/brief